Search research articles
Contact Us
Filters
Showing results (241-250 of 292) with videos related to
Page
of 30
Sort By:
The Lancet. Psychiatry
|
November 5, 2025
Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics
Jurjen J Luykx, Mark Colgan, Eduard Vieta, et al.
BMJ Open
|
March 4, 2018
CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine
Dan Siskind, Nadia Friend, Anthony Russell, et al.
General Hospital Psychiatry
|
March 31, 2022
Assessing dietary, exercise, and non-pharmacological modalities within psychiatric hospitals
Najwa-Joelle Metri, Carolyn Ee, Jon Wardle, et al.
Expert Opinion on Drug Safety
|
November 27, 2019
The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy
Kenya A Costa-Dookhan, Sri Mahavir Agarwal, Araba Chintoh, et al.
Therapeutic Advances in Psychopharmacology
|
October 21, 2021
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
Dan Siskind, Anthony W Russell, Shuichi Suetani, et al.
Therapeutic Advances in Psychopharmacology
|
April 28, 2023
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series
Femin Prasad, Riddhita De, Vittal Korann, et al.
The Australian and New Zealand Journal of Psychiatry
|
November 11, 2025
The feasibility of resistance training versus aerobic exercise in a rehabilitation setting for people living with psychotic disorders: A randomised controlled trial
Nicole Korman, Robert Stanton, Mike Trott, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 3, 2022
The role of metformin as a treatment for neuropsychiatric illness
Seetal Dodd, Luba Sominsky, Dan Siskind, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
December 16, 2014
Getting started in research: systematic reviews and meta-analyses
Stephen Kisely, Alice Chang, Jim Crowe, et al.
Bjpsych Open
|
July 22, 2025
Schizophrenia, Nutrition and Choices in Kilojoules (SNaCK): protocol for a feasibility and acceptability randomised controlled trial of two dietary interventions
Donni Johnston, Urska Arnautovska, Andrea Baker, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 292) with videos related to
Sort By:
Page
of 30
The Lancet. Psychiatry
|
November 5, 2025
Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics
Jurjen J Luykx, Mark Colgan, Eduard Vieta, et al.
BMJ Open
|
March 4, 2018
CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine
Dan Siskind, Nadia Friend, Anthony Russell, et al.
General Hospital Psychiatry
|
March 31, 2022
Assessing dietary, exercise, and non-pharmacological modalities within psychiatric hospitals
Najwa-Joelle Metri, Carolyn Ee, Jon Wardle, et al.
Expert Opinion on Drug Safety
|
November 27, 2019
The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy
Kenya A Costa-Dookhan, Sri Mahavir Agarwal, Araba Chintoh, et al.
Therapeutic Advances in Psychopharmacology
|
October 21, 2021
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
Dan Siskind, Anthony W Russell, Shuichi Suetani, et al.
Therapeutic Advances in Psychopharmacology
|
April 28, 2023
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series
Femin Prasad, Riddhita De, Vittal Korann, et al.
The Australian and New Zealand Journal of Psychiatry
|
November 11, 2025
The feasibility of resistance training versus aerobic exercise in a rehabilitation setting for people living with psychotic disorders: A randomised controlled trial
Nicole Korman, Robert Stanton, Mike Trott, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 3, 2022
The role of metformin as a treatment for neuropsychiatric illness
Seetal Dodd, Luba Sominsky, Dan Siskind, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
December 16, 2014
Getting started in research: systematic reviews and meta-analyses
Stephen Kisely, Alice Chang, Jim Crowe, et al.
Bjpsych Open
|
July 22, 2025
Schizophrenia, Nutrition and Choices in Kilojoules (SNaCK): protocol for a feasibility and acceptability randomised controlled trial of two dietary interventions
Donni Johnston, Urska Arnautovska, Andrea Baker, et al.
Page
of 30